Literature DB >> 25238104

High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.

Anna Bonjoch1, Javier Juega, Jordi Puig, Nuria Pérez-Alvarez, Aintzane Aiestarán, Patricia Echeverría, Vanessa Pérez, Bonaventura Clotet, Ramon Romero, Josep Bonet, Eugenia Negredo.   

Abstract

Renal disorders are an emerging problem in HIV-infected patients. We performed a cross-sectional study of the first 1000 HIV-infected patients attended at our HIV unit who agreed to participate. We determined the frequency of renal alterations and its related risk factors. Summary statistics and logistic regression were applied. The study sample comprised 970 patients with complete data. Most were white (94%) and men (76%). Median (IQR) age was 48 (42-53) years. Hypertension was diagnosed in 19%, dyslipidemia in 27%, and diabetes mellitus in 3%. According to the Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) equation, 29 patients (3%) had an eGFR<60 ml/min/1.73 m(2); 18 of them (62%) presented altered albumin/creatinine and protein/creatinine (UPC or UAC) ratios. Of the patients with eGFR>60 mL/min, it was present in 293 (30%), 38 of whom (7.1%) had UPC>300 mg/g. Increased risk of renal abnormalities was correlated with hypertension (OR, 1.821 [95%CI, 1.292;2.564]; p=0.001), age (OR, 1.015 [95%CI, 1.001;1.030], per one year; p=0.040), and use of tenofovir disoproxil fumarate (TDF) plus protease inhibitor (PI), (OR, 1.401 [95%CI, 1.078;1.821]; p=0.012). Current CD4 cell count was a protective factor (OR, 0.9995 [95%CI, 0.9991;0.9999], per one cell; p=0.035). A considerable proportion of patients presented altered UPC or UAC ratios, despite having an eGFR>60 mL/min. CD4 cell count was a protective factor; age, hypertension, and use of TDF plus PIs were risk factors for renal abnormalities. Based on our results, screen of renal abnormalities should be considered in all HIV-infected patients to detect these alterations early.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25238104     DOI: 10.1089/apc.2014.0172

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  12 in total

1.  Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.

Authors:  Vasantha Jotwani; Rebecca Scherzer; David V Glidden; Megha Mehrotra; Patricia Defechereux; Albert Liu; Monica Gandhi; Michael Bennett; Steven G Coca; Chirag R Parikh; Robert M Grant; Michael G Shlipak
Journal:  J Acquir Immune Defic Syndr       Date:  2018-06-01       Impact factor: 3.731

Review 2.  Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Authors:  Vasantha Jotwani; Mohamed G Atta; Michelle M Estrella
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

3.  Brief Report: Cumulative Tenofovir Disoproxil Fumarate Exposure is Associated With Biomarkers of Tubular Injury and Fibrosis in HIV-Infected Men.

Authors:  Vasantha Jotwani; Rebecca Scherzer; Michelle M Estrella; Lisa P Jacobson; Mallory D Witt; Frank Palella; Bernard Macatangay; Michael Bennett; Chirag R Parikh; Joachim H Ix; Michael Shlipak
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

Review 4.  Mechanisms Influencing Circadian Blood Pressure Patterns Among Individuals with HIV.

Authors:  Shia T Kent; Greer A Burkholder; Gabriel S Tajeu; E Turner Overton; Paul Muntner
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

5.  HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study.

Authors:  Vasantha Jotwani; Rebecca Scherzer; Michelle M Estrella; Lisa P Jacobson; Mallory D Witt; Frank J Palella; Bernard Macatangay; Michael Bennett; Chirag R Parikh; Joachim H Ix; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2016-06-08       Impact factor: 8.860

Review 6.  A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science.

Authors:  Allison R Webel; Julie Schexnayder; Patricia A Cioe; Julie A Zuñiga
Journal:  J Assoc Nurses AIDS Care       Date:  2021 May-Jun 01       Impact factor: 1.809

Review 7.  Urinary Markers of Tubular Injury in HIV-Infected Patients.

Authors:  Temesgen Fiseha; Angesom Gebreweld
Journal:  Biochem Res Int       Date:  2016-07-17

8.  Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.

Authors:  Soichiro Suzuki; Takeshi Nishijima; Yohei Kawasaki; Takuma Kurosawa; Yoshikazu Mutoh; Yoshimi Kikuchi; Hiroyuki Gatanaga; Shinichi Oka
Journal:  AIDS Patient Care STDS       Date:  2017-03       Impact factor: 5.078

Review 9.  Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis.

Authors:  Udeme E Ekrikpo; Andre P Kengne; Aminu K Bello; Emmanuel E Effa; Jean Jacques Noubiap; Babatunde L Salako; Brian L Rayner; Giuseppe Remuzzi; Ikechi G Okpechi
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

10.  Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study.

Authors:  Anna Bonjoch; Jordi Puig; Nuria Pérez-Alvarez; Javier Juega; Patricia Echeverría; Bonaventura Clotet; Ramón Romero; J Bonet; E Negredo
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.